Pharmaceutical companies have begun using social media for business needs and promotion, yet have been hesitant to become too engaged since the FDA’s stance on social media activity remained unclear.
Pharmaceutical companies have begun using social media for business needs and promotion, yet have been hesitant to become too engaged since the FDA’s stance on social media activity remained unclear. But now that we know the FDA’s specific guidelines for pharma companies’ actions online, it’s time for brands to consider diving into the social media pool.
What FDA Regulations Mean for You
But before we dive in too deep, here’s a refresher on what the FDA guidelines do:
How to Make the Most of Social Media (Within FDA Guidelines)
So, what does that mean for your company?
The FDA guidelines simply outline the proper use and behavior of pharma companies utilizing social media, just as there are guidelines for drug testing, marketing, and label warnings. With this new information, here’s what your company should do:
Making Pharma and Social Media Work Together
There are already great examples of pharma companies using social media in innovative ways. At last year’s European Respiratory Society Congress, Boehringer Ingelheim became the first pharmaceutical company to host a disease-focused Twitter hangout. Using #COPDChat to spawn conversations over four continents, the hangout made more than 1.7 million impressions and led to a 7-percent jump in the number of Twitter followers for the company.
Sanofi has fostered trust with its users by being forthright about its policies on monitoring user content on Internet properties. User comments are quarantined - delayed up to 24 hours before appearing publicly - so a Sanofi team member can provide additional information to clarify user questions or comments. Sanofi’s online community values its efforts to provide thorough and accurate information while maintaining transparency.
Device company Medtronic has made itself highly approachable to consumers by having a presence on Facebook, Twitter, LinkedIn, and YouTube, where users can ask questions directly of the company and receive enthusiastic responses and helpful information. That accessibility is part of the reason Medtronic now has more than 154,000 Facebook fans.
Just as social media changed the way our society communicates, it can change the way a pharma company interacts with consumers, promotes products or services, and is perceived by the public.
Establishing social media accounts for your brand will empower consumers to seek additional information, report issues, and provide feedback. At the same time, it allows you the opportunity to correct misinformation, soothe agitated customers, offer helpful resources, and display goodwill toward consumers. If your company uses these social media tips, you’ll be more engaged with and trusted by customers than ever before.
Ken Ribotsky is CEO of Brandkarma LLC. He can be reached at Kenneth.ribotsky@yahoo.com
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
2 Commerce Drive
Cranbury, NJ 08512